MEGAN MICEK: Open Payments
NPI 1558054031 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,210 in 107 payments from 26 companies in 2025. Trend: 2023 $318 · 2024 $1,757 · 2025 $2,210
Food & beverage: $2,210
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $191 |
| Lilly USA, LLC | 9 | $165 |
| Exact Sciences Corporation | 7 | $161 |
| AstraZeneca Pharmaceuticals LP | 7 | $156 |
| Novo Nordisk Inc | 8 | $145 |
| PFIZER INC. | 9 | $143 |
| Dexcom, Inc. | 2 | $141 |
| ABBVIE INC. | 5 | $101 |
| Astellas Pharma US Inc | 4 | $100 |
Products named: TRELEGY ELLIPTA, CAPLYTA, DEXCOM G7 GSS (161), REXULTI, Cologuard Collection Kit, MOUNJARO, Veozah, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
